Tissue Science Conference | Regenerative Medicine Conference | Stem Cell Conference | Cell Science Conferences | Rome | Itay| Asia | Europe | Middle East

Theme: Redefining Health Care through Tissue Engineering

tissuescience 2021

Tentative Program TISSUESCIENCE 2021

tissuescience 2021

Tissue Science 2021 proudly invites contributors across the globe to attend “International Conference on Tissue Science and Regenerative Medicine” during December 01-02, 2021 in Rome, Italy which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Tissue Science 2021 is mainly based on the theme “Redefining Health Care through Tissue Engineering”. We warmly welcome all the participants of world’s leading Scientists, Researchers and Scholars. We provide a platform for young researchers and students to present their research through oral presentations through which they can develop a foundation for collaboration among young researchers.

The organising committee aims at setting a platform for all the budding scientists and researchers to present their real-time work and share their views and aspects related to the theme of the conference. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world.

ConferenceSeries LLC Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1: Tissue Engineering

Tissue engineering evolved from the field of biomaterials development and refers to the practice of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.

Track 2: Gene and Immunotherapy

Gene therapy is an experimental technique that uses genes to treat or prevent disease and immunotherapy is the treatment to stimulate or restore the ability of the immune (defence) system to fight infection and disease. Genetic immunization refers to treatment strategies where gene transfer methods are used to generate immune responses against diseases like Cancer. Our growing knowledge of the mechanisms regulating the initiation and maintenance of cytotoxic immune responses has provided the rationale for the design of several genetic immunization strategies. Tumor cells have been gene-modified to express immune stimulatory genes and are then administered as tumour vaccines, in an attempt to overcome tumour cell ignorance by the immune system. With the description of well-characterized tumour antigens, multiple strategies have been proposed mainly aimed at optimal tumour antigen presentation by antigen-presenting cells (APC).

Track 3: Biomaterials and Bioengineering

Biomaterials are being used for the healthcare applications from ancient times. But subsequent evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel strategies to combat life threatening diseases. Together with biomaterials, stem cell technology is also being used to improve the existing healthcare facilities. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc.

Track 4: Cell and Organ Regeneration

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.

Regenerative Approaches with

Nanoparticles
Decellularization
Blastocyst Complementation
Advanced Developments in Artificial Organ System

Track 5: Biotechnology and nanotechnology in stem cells

Nanotechnology and Biotechnology may provide new strategies for regenerative medicine, including better tools to improve or restore damaged tissues, according to a review paper that summarizes the current state of knowledge on nanotechnology with application to stem cell biology. Researchers have found that the adhesion, growth, and differentiation of stem cells are likely controlled by their surrounding microenvironment, which contains both chemical and physical cues. These cues include the “Nano topography” and biotechnology of the complex extracellular matrix or architecture that forms a network for human tissues.

Track 6: Soft Tissue Replacement

In soft tissue implants, as in other applications that involve engineering, the performance of an implanted device depends upon both the materials used and the design of the device or implant. The initial selection of material should be based on sound materials engineering practice. The final judgment on the suitability of a material depends upon observation of the in-vivo clinical performance of the implant. Such observations may require many years or decades. This requirement of in-vivo observation represents one of the major problems in the selection of appropriate materials for use in the human body. Another problem is that the performance of an implant may also depend on the design rather than the materials themselves. Even though one may have an ideal material and design, the actual performance also greatly depends on the skill of the surgeons and the prior condition of patients.

Track 7: Stem Cell Bioprocessing

In recent years, the potential of stem cell research for tissue engineering-based therapies and regenerative medicine clinical applications has become well established. In 2006, Chung pioneered the first entire organ transplant using adult stem cells and a scaffold for clinical evaluation. With this a new milestone was achieved, with seven patients with myelomeningocele receiving stem cell-derived bladder transplants resulting in substantial improvements in their quality of life. While a bladder is a relatively simple organ, the breakthrough highlights the incredible benefits that can be gained from the cross-disciplinary nature of tissue engineering and regenerative medicine (TERM) that encompasses stem cell research and stem cell bioprocessing.

Track 8: Regenerative Rehabilitation

Regenerative Rehabilitation is the integration of principles and approaches from rehabilitation and regenerative medicine with the ultimate goal of developing innovative and effective methods that promote the restoration of function through tissue regeneration and repair.

Track 9: Anti-Aging, Regenerative and functional Medicine

Anti-Aging Medicine is dedicated to the advancement of technological tools and breakthrough transformations in healthcare that can detect, treat, and prevent diseases associated with aging. The Anti-Aging medicine promotes the research of practices and protocols that collectively have the potential to optimize the human aging process, with the development of therapeutic protocols and innovative diagnostic tools that can effectively spur longevity treatments.

Track 10: Biomedical Engineering Techniques

Biomedical engineering approaches to help aid in the detection and treatment of tropical diseases such as dengue, malaria, cholera, schistosomiasis, lymphatic filariasis, ebola, leprosy, leishmaniasis, and American trypanosomiasis (Chagas). Many different forms of non-invasive approaches such as ultrasound, echocardiography and electrocardiography, bioelectrical impedance, optical detection, simplified and rapid serological tests such as lab-on-chip and micro-/nano-fluidic platforms and medical support systems such as artificial intelligence clinical support systems are included in Biomedical Engineering Techniques.

Track 11: Artificial Organs

Artificial Organs introduces to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. Artificial Organs encompasses to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs.

Track 12: Applications of Tissue Engineering

Tissue Engineering (TE) is a scientific field mainly focused on the development of tissue and organ substitutes by controlling biological, biophysical and/or biomechanical parameters in the laboratory. The result corresponds, in most cases, to the elaboration of three-dimensional cellular constructs with properties more similar to natural tissues than classical monolayer cultures. These systems enable the in vitro study of human physiology and physiopathology more accurately, while providing a set of biomedical tools with potential applicability in toxicology `7m j, medical devices, tissue replacement, repair and regeneration.

Track 13: Tissue Repair and Regeneration

Deregulation of normal tissue repair has dramatic consequences for life quality and survival of patients. Together, insufficient healing (chronic wounds) and excessive repair after injury (scarring/fibrosis) cause healthcare costs reaching tens of billions of dollars per year in the US alone. Chronic and fibrotic healing occurs when the body’s own repair capacity is either impaired or overwhelmed. One approach in regenerative medicine is to replace injured, diseased or aged tissues with functional tissue equivalents. This approach is challenged by adverse host reactions that are part of the body repair program, e.g., immune, inflammatory, and fibrotic responses. Thus, regenerative medicine increasingly considers to support the adult's body's own regenerative capacities to promote closure of wounds that never heal and to keep excessive repair at bay. However, it is still unclear why humans lost regenerative capacity during evolution, whereas lower organisms can regenerate whole organs.

Track 14: Stem Cell Treatments

Stem cells have tremendous promise to help us understand and treat a range of diseases, injuries and other health-related conditions. Their potential is evident in the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukaemia; and can be seen in the use of stem cells for tissue grafts to treat diseases or injury to the bone, skin and surface of the eye. Important clinical trials involving stem cells are underway for many other conditions and researchers continue to explore new avenues using stem cells in medicine.

Track 15: Cellular and gene Therapies

Human cell therapy and gene therapy is the administration of cellular and genetic material to modify or manipulate the expression of a gene product or to alter the biological properties of living cells for therapeutic use. Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms: Replacing a disease-causing gene with a healthy copy of the gene, inactivating a disease-causing gene that is not functioning properly, introducing a new or modified gene into the body to help treat a disease.

Track 16: Bone Tissue Engineering

Bone Tissue Engineering in the field of Regenerative Medicine has been the topic of substantial research over the past two decades. Technological advances have improved orthopaedic implants and surgical techniques for bone reconstruction. Bone tissue engineering is concerned with creating implantable bone substitutes for critical skeletal defects that cannot heal on their own. These defects are common clinical scenarios in orthopedics and craniofacial surgery, for the treatment of bone loss due to trauma, infection, and tumor resection. In the conventional tissue-engineering paradigm, combinations of cells and bioactive molecules are seeded onto three-dimensional biomaterial scaffolds to create an implantable ‘osteogenic’ implant.

Track 17: Bio Banking

Biobanks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalogue specimens using genetic and other traits, such as age, gender, blood type, and ethnicity.

Track 18: Regenerative Medicine Market

The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%.

The global market is broadly classified into types, therapy, application and regions. Based on types, the market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2018.Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period.

This market is also segmented by application. By application, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications.

Market Analysis Report:

Tissue Science 2021 is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies

Currently, it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like the UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

Today’s Market Study of Tissue Science and Regenerative Medicine in USA | Europe | Middle East | Asia Pacific

USA: Regenerative medicines market by therapy (cell therapy, gene therapy, immunotherapy, tissue engineering), region - global forecast to 2021, the global regenerative medicines market size is expected to reach USD 49.41 billion by 2021.

Europe: The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019.

Middle East: The Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021.

Asia-Pacific: Asia-Pacific regenerative medicines market is expected to reach USD 10.71 billion by 2021 from USD 3.01 billion in 2016, growing at a CAGR of 28.90% during the forecast period 2016-2021.

Universities of Tissue Engineering & Regenerative Medicine

Universitat Autònoma de Barcelona
Universitat de Barcelona
University of Navarra
Universitat Rovira I Virgili
University of Granada
University of the Basque Country
University of Valencia
University of Zaragoza
King Juan Carlos University
The University of Oviedo
Universidad de Castilla la Mancha
University of Alcalá
University of La Laguna
University of Murcia
University of Salamanca
University of Santiago de Compostela
University of Seville
University of Vigo
University of Madrid

Why to attend???

With members from around the world focused on learning about Tissue Science 2021; this is your best opportunity to reach the largest assemblage of participants from the Tissue Science and Regenerative Medicine community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Tissue Science and Regenerative Medicine are hallmarks of this conference.

Targeted Audience:

Regenerative Medicine Researchers & Scientists
Tissue Engineering Researchers & Scientists
Tissue Science Associations and Societies
Regenerative Medicine Associations and Societies
Tissue Science and Regenerative Medicine Academic professors
Tissue Science and Regenerative Medicine Investors
Global Tissue Science and Regenerative Medicine Companies
Cell and Molecular biology researchers
Cell and Tissue engineering Laboratory Heads
Stem Cell Academic professors & researchers
Cell Biologists
Genetics and cell biology experts
Tissue engineering experts
Doctors and students prominent in cell therapy
Biomedical Engineers
Bio Medicine Researchers
Biotechnologists
Training Institutes
Exhibitors and Sponsors
Business Scholars from Industries & Entrepreneurs

Tissue Science 2020, provides the participants with different modes or ways to participate under either ACADEMIC / STUDENT / BUSSINESS Category

SPEAKER (Oral Presentation) : 25-30 minutes (only one person can present)
SPEAKER (Workshop) : 45-50 minutes (more than 1 can present)
SPEAKER (Special Session) : 45-50 minutes (more than 1 can present)
SPEAKER (Symposium) : more than 45 minutes (more than 1 can present)
DELEGATE(only registration): Will have access to all the sessions with all the benefits of registration
POSTER PRESENTER: Can present a poster and avail the benefits of delegate
REMOTE ATTENDENCE: Can participate via VIDEO presentation or E-poster presentation
EXHIBITOR: Can exhibit his/her company’s products by booking exhibitor booths of different sizes
MEDIA PARTNER
SPONSOR
COLLABORATOR

For Researchers & Faculty:

Speaker Presentations
Poster Display
Symposium hosting
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Group Participation

For Students & Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group Registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Companies:

Exhibitor and Vendor Booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 01-02, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

13^thInternational Conference on Tissue Science and Regenerative Medicine December 01-02, 2021 Rome, Italy

Recommended Global Genetics & Molecular Biology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com